Pernille Jul Jul Clemmensen

Mrs. Pernille Jul Jul Clemmensen

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 July 2023 in Current Environmental Health Reports
Verified
Journal Article
Open access
PDF file
PCPernille Jul Jul Clemmensen
Pernille Jul Jul Clemmensen
JSJörg Schullehner
Jörg Schullehner
NBNis Brix
Nis Brix
TSTorben Sigsgaard
Torben Sigsgaard
LSLeslie Thomas Stayner
Leslie Thomas Stayner
CRCecilia Høst Ramlau-Hansen
Cecilia Høst Ramlau-Hansen
Purpose of Review: Recently, several epidemiological studies have investigated whether prenatal exposure to nitrate from drinking water may be harmful to the fetus, even at nitrate levels below the current World Health Organization drinking water standard. The purpose of this review was to give an overview of the newest knowledge on potential health effects of prenatal exposure to nitrate.Recent Findings: We included 13 epidemiological studies conducted since 2017. Nine studies investigated outcomes appearing around birth, and four studies investigated health outcomes appearing in childhood and young adulthood.Summary: The reviewed studies showed some indications of higher risk of preterm delivery, lower birth weight, birth defects, and childhood cancer related to prenatal exposure to nitrate. However, the numbers of studies for each outcome were sparse, and some of the results were conflicting. We suggest that there is a need for additional studies and particularly for studies that include information on water consumption patterns, intake of nitrate from diet, and intake of nitrosatable drugs.

24 November 2022 in Environment International
Verified
Journal Article
Open access
PCPernille Jul Jul Clemmensen
Pernille Jul Jul Clemmensen
NBNis Brix
Nis Brix
JSJörg Schullehner
Jörg Schullehner
LLLea Lykke Harrits Lunddorf
Lea Lykke Harrits Lunddorf
AEAndreas Ernst
Andreas Ernst
CRCecilia Høst Ramlau-Hansen
Cecilia Høst Ramlau-Hansen
In Western countries, age at pubertal development has declined during the last century in girls, and probably also in boys. No studies have investigated whether nitrate, a widespread environmental exposure with teratogenic and hormone disrupting properties, might affect timing of puberty. We investigated if prenatal exposure to nitrate from drinking water and diet was associated with timing of puberty. This cohort study included 15,819 children born from 2000 to 2003 within the Danish National Birth Cohort. Self-reported information on current status of various pubertal milestones was provided every six months by a questionnaire from 11 years of age until 18 years or full maturity, whichever came first. Maternal nitrate intake from diet (mg/day) was derived from a mid-pregnancy food frequency questionnaire and individual level nitrate exposure from drinking water (mg/L) was derived using measurements from Danish public waterworks. Adjusted average differences in months in age at attaining several pubertal milestones as well as the average age difference in age at attaining all the milestones were estimated separately for diet and water using a regression model for interval-censored data. C- and E-vitamin, red meat and processed meat intake were explored as potential effect modifiers in sub-analyses. No strong associations were observed between prenatal exposure to nitrate and timing of puberty in children. However, sons born of mothers with a nitrate concentration in drinking water at their residential address of > 25 mg/L (half of the World Health Organisation (WHO) guideline value) compared with ≤ 1 mg/L showed a tendency towards earlier age at pubertal development with an average age difference of -1.2 months (95 % confidence interval,-3.0;0.6) for all the pubertal milestones combined. Studies including more highly exposed children are needed before the current WHO drinking water guideline value for nitrate can be considered safe concerning pubertal development.

1 April 2022 in Clinical Epidemiology
Verified
Journal Article
Open access
PDF file
NENinna Ebdrup
Ninna Ebdrup
UKUlla Breth Knudsen
Ulla Breth Knudsen
JSJörg Schullehner
Jörg Schullehner
LALinn Håkonsen Arendt
Linn Håkonsen Arendt
ZLZeyan Liew
Zeyan Liew
CRCecilia Høst Ramlau-Hansen
Cecilia Høst Ramlau-Hansen
Purpose: No studies have investigated if drinking water nitrate affects human fecundity. Experimental studies point at detrimental effects on fetal development and on female and male reproduction. This cohort study aimed to explore if female and male preconception and long-term exposure to nitrate in drinking water was associated with fecundability measured as time to pregnancy (TTP) or use of medically assisted reproduction (MAR) treatment. Methods: The study population consisted of pregnant women recruited in their first trimester in 1996– 2002 to the Danish National Birth Cohort. Preconception drinking-water nitrate exposure was estimated for the pregnant women (89,109 pregnancies), and long-term drinking water nitrate exposure was estimated from adolescence to conception for the pregnant women (77,474 pregnancies) and their male partners (62,000 pregnancies) by linkage to the national drinking water quality-monitoring database Jupiter. Difference in risk of TTP > 12 months or use of MAR treatment between five exposure categories and log-transformed continuous models of preconception and long-term nitrate in drinking water were estimated. Binominal regression models for risk ratios (RR) were adjusted for age, occupation, education, population density, and lifestyle factors. Results: Nitrate in drinking water (median preconception exposure: 1.9 mg/L; median long-term exposure: 3.3 mg/L) was not associated with TTP > 12 months or use of MAR treatment, neither in the categorical nor in the continuous models. Conclusion: We found no association between preconception or long-term exposure to drinking water nitrate and fecundability.

PCPernille Jul Jul Clemmensen
Pernille Jul Jul Clemmensen
NBNis Brix
Nis Brix
JSJörg Schullehner
Jörg Schullehner
AGAnne Gaml-Sørensen
Anne Gaml-Sørensen
Gunnar ToftGunnar Toft
Gunnar Toft
CRCecilia Høst Ramlau-Hansen
Cecilia Høst Ramlau-Hansen
Animal studies indicate deleterious effects of nitrate exposure on fecundity, but effects in humans are unknown, both for the prenatal and postnatal periods. We aimed to investigate if exposure to nitrate in maternal drinking water during the sensitive period of fetal life is associated with measures of fecundity in the adult sons. In a sub-analysis, the potential effects of nitrate exposure in adulthood were investigated. This cohort included 985 young adult men enrolled in The Fetal Programming of Semen Quality Cohort (FEPOS). Semen characteristics, testes volume and reproductive hormones were analyzed in relation to nitrate concentration in maternal drinking water, using a negative binomial regression model. The nitrate concentration in drinking water was obtained from monitoring data from Danish waterworks that were linked with the mothers’ residential address during pregnancy. The median nitrate concentration in maternal drinking water was 2 mg/L. At these low exposure levels, which are far below the World Health Organization’s (WHO) guideline value of 50 mg/L, we did not find indications of harmful effects of nitrate on the investigated measures of male fecundity.

8 December 2025 in Human Reproduction Open
Verified
Journal Article
Open access
CKCamilla L Kjersgaard
Camilla L Kjersgaard
AGAnne Gaml-Sørensen
Anne Gaml-Sørensen
PCPernille Jul Jul Clemmensen
Pernille Jul Jul Clemmensen
LALinn H Arendt
Linn H Arendt
SHSiri E Håberg
Siri E Håberg
CRCecilia H Ramlau-Hansen
Cecilia H Ramlau-Hansen
STUDY QUESTION: Do women with atopic dermatitis have higher fecundity than those without? SUMMARY ANSWER: Pregnant women with a history of atopic dermatitis had a slightly shorter time-to-pregnancy (TTP) and a lower risk of conceiving using infertility treatment than those without. WHAT IS KNOWN ALREADY: Atopic dermatitis has a characteristic T-helper-2-cell-skewed immune response that mirrors the immune shift in pregnancy, which is necessary for the pregnant woman’s immune response to tolerate the fetus. Therefore, it has been hypothesized that atopic dermatitis may be advantageous for conception and pregnancy maintenance. However, this has not yet been investigated. STUDY DESIGN, SIZE, DURATION: This cohort study included 88 713 pregnant women from the population-based Danish National Birth Cohort (DNBC), who were enrolled between 1996 and 2002. PARTICIPANTS/MATERIALS, SETTING, METHODS: The women were defined as having atopic dermatitis if, in a computer-assisted interview conducted around gestational week 17, they reported having ever been diagnosed with atopic dermatitis by a doctor. The women were also asked whether the pregnancy was planned or unplanned, to report their TTP within one of five prespecified categories, and whether they had conceived with the use of infertility treatment. We used multinomial logistic regression models to assess associations between atopic dermatitis and fecundity in seven categories: (TTP 12 months, pregnant after infertility treatment or unplanned). In addition, we modeled TTP as dichotomous outcomes using logistic regression: subfecundity (TTP ≥6 months vs 12 months vs ≤12 months). We also assessed women with an atopic constitution (atopic dermatitis, allergic rhinitis, asthma, and food allergies), as this is associated with more severe atopic dermatitis. MAIN RESULTS AND THE ROLE OF CHANCE: Overall, 3641 (4.1%) women reported ever having had atopic dermatitis. Compared to women without atopic dermatitis, women with atopic dermatitis had a lower relative risk ratio (RRR) of having a TTP >12 months: 0.83 (95% CI: 0.72; 0.96), and use of infertility treatment, RRR: 0.81 (95% CI: 0.69; 0.94). Moreover, women with atopic dermatitis had a lower odds ratio (OR) of subfecundity: 0.89 (95% CI: 0.82; 0.96) and infertility: 0.85 (95% CI: 0.77; 0.95) than women without in the logistic regression model. Results were robust across several sub-analyses. LIMITATIONS, REASONS FOR CAUTION: The results can only be generalized to women who eventually conceive, since the DNBC consists only of women who successfully conceived. WIDER IMPLICATIONS OF THE FINDINGS: The findings support the hypothesis of an immunological benefit in conceiving when having atopic dermatitis. The results are reassuring for women with atopic dermatitis trying to conceive. However, the hypothesis should be further tested in a broader population of women without conditioning on pregnancy. STUDY FUNDING/COMPETING INTEREST(S): The work was supported by the Danish Council for Independent Research (grant number DFF—1030-00164B), Aarhus University, and Fonden af Fam. Kjærsgaard, Sunds, the Research Council of Norway (project no. 320656), through its Centres of Excellence funding scheme (project no. 262700), and co-funded by the European Union (ERC, BIOSFER, 101071773). However, views and opinions expressed herein are those of the author(s) only and do not necessarily reflect those of the European Union or the European Research Council. Neither the European Union nor the granting authority can be held responsible. This publication is part of the ReproUnion collaborative study, co-financed by the European Union, Intereg V ÖKS (20200407). M.D. has received consulting fees (including participation on advisory boards) from AbbVie, LEO Pharma, Eli Lilly, Incyte, La Roche Posay, NUMAB Therapeutics, Pfizer, Regeneron Pharmaceuticals Inc., Sanofi Genzyme, Almirall, Union Therapeutics, Kymab, and UCB; travel support from LEO Pharma and Sanofi Genzyme; speaker fees from Mustela, Galderma, Leo Pharma, Sanofi Genzyme, and La Roche Posay; Section editor for Journal of the European Academy of Dermatology and Venereology (JEADV). None of these COIs is relevant to the present article. The remaining authors declare that they have no conflicts of interest. TRIAL REGISTRATION NUMBER: N/A.

9 October 2023 in International Journal of Hygiene and Environmental Health
Verified
Journal Article
Open access
PCPernille Jul Jul Clemmensen
Pernille Jul Jul Clemmensen
NBNis Brix
Nis Brix
JSJörg Schullehner
Jörg Schullehner
AEAndreas Ernst
Andreas Ernst
LLLea Lykke Harrits Lunddorf
Lea Lykke Harrits Lunddorf
CRCecilia Høst Ramlau-Hansen
Cecilia Høst Ramlau-Hansen
N-nitroso compounds (NOCs) can be formed by endogenous reactions between nitrosatable drugs and nitrite. Animal studies have found that several NOCs are teratogenic, and epidemiological studies report associations between prenatal exposure to nitrosatable drugs and adverse birth outcomes. It is unknown whether prenatal exposure to nitrosatable drugs is harmful to the child's reproductive health, including pubertal development. We investigated whether prenatal exposure to nitrosatable drugs was associated with timing of puberty and whether nitrate, nitrite and antioxidant intake modified any association. The population-based Danish National Birth Cohort (DNBC) Puberty Cohort, which includes 15,819 children, was used to investigate the association between prenatal exposure to nitrosatable drugs and timing of puberty. Around gestational week 11 and gestational week 18, mothers provided information about drug use during pregnancy. The children's self-reported information on onset of pubertal milestones was collected every six months from 11 years of age and throughout puberty. To investigate potential effect modification by nitrite, nitrate and antioxidant intake, information on these factors was obtained from a food frequency questionnaire completed by the mothers in gestational week 25, and information on nitrate concentration in maternal drinking water at her residential address was obtained from monitoring data from public waterworks. Data were analysed using a multivariable regression model for interval-censored data estimating difference in months in timing of puberty between exposure groups. A total of 2,715 children were prenatally exposed to nitrosatable drugs. We did not find an association between prenatal exposure to nitrosatable drugs and timing of puberty. This finding was supported by null-findings in the following sub-analyses investigating: 1. subtypes of nitrosatable drugs (secondary and tertiary amines and amides), 2. dose-dependency (duration of drug intake), 3. effect modification by maternal intake of nitrate, nitrite, and antioxidants. 4. confounding by indication. Prenatal exposure to nitrosatable drugs was not associated with timing of puberty. Nitrosatable drugs are commonly used drugs in pregnancy, and further research is needed to allow firm conclusions on the potential effect of prenatal exposure to nitrosatable drugs on the child's reproductive health.